RESUMO
Background: SARS-CoV-2 pandemic has modified the cardiovascular care of ambulatory patients. The aim of this survey was to study changes in lifestyle habits, treatment adherence, and mental health status in patients with cardiometabolic disease, but no clinical evidence of COVID-19. Methods: A cross-sectional survey was conducted in ambulatory patients with cardiometabolic disease using paper/digital surveys. Variables investigated included socioeconomic status, physical activity, diet, tobacco use, alcohol intake, treatment discontinuation, and psychological symptoms. Results: A total of 4,216 patients (50.9% males, mean age 60.3 ± 15.3 years old) from 13 Spanish-speaking Latin American countries were enrolled. Among the study population, 46.4% of patients did not have contact with a healthcare provider, 31.5% reported access barriers to treatments and 17% discontinued some medication. Multivariate analysis showed that non-adherence to treatment was more prevalent in the secondary prevention group: peripheral vascular disease (OR 1.55, CI 1.08-2.24; p = 0.018), heart failure (OR 1.36, CI 1.05-1.75; p = 0.017), and coronary artery disease (OR 1.29 CI 1.04-1.60; p = 0.018). No physical activity was reported by 38% of patients. Only 15% of patients met minimum recommendations of physical activity (more than 150 minutes/week) and vegetable and fruit intake. Low/very low income (45.5%) was associated with a lower level of physical activity (p < 0.0001), less fruit and vegetables intake (p < 0.0001), more tobacco use (p < 0.001) and perception of depression (p < 0.001). Low educational level was also associated with the perception of depression (OR 1.46, CI 1.26-1.70; p < 0.01). Conclusions: Patients with cardiometabolic disease but without clinical evidence of COVID-19 showed significant medication non-adherence, especially in secondary prevention patients. Deterioration in lifestyle habits and appearance of depressive symptoms during the pandemic were frequent and related to socioeconomic status.
Assuntos
COVID-19 , Doenças Cardiovasculares/terapia , Depressão/psicologia , Diabetes Mellitus/terapia , Dieta , Dislipidemias/terapia , Exercício Físico , Cooperação e Adesão ao Tratamento/estatística & dados numéricos , Adulto , Idoso , Consumo de Bebidas Alcoólicas/epidemiologia , Arritmias Cardíacas/terapia , Fatores de Risco Cardiometabólico , Fumar Cigarros/epidemiologia , Doença da Artéria Coronariana/terapia , Escolaridade , Feminino , Acessibilidade aos Serviços de Saúde , Insuficiência Cardíaca/terapia , Humanos , Hipertensão/terapia , América Latina/epidemiologia , Masculino , Saúde Mental , Pessoa de Meia-Idade , Pacientes Ambulatoriais , Doenças Vasculares Periféricas/terapia , SARS-CoV-2 , Prevenção Secundária , Classe Social , Inquéritos e QuestionáriosRESUMO
OBJECTIVE: Endovascular treatment for femoropopliteal arterial disease has made revascularization procedures less invasive, but the self-expanding stents used can suffer great wear in arteries with extreme mobility. To evaluate the prevalence of fractures in stents implanted in the femoropopliteal segment, to identify predisposing factors and consequences on arterial patency. METHOD: between March and June 2019, thirty patients previously operated for femoropopliteal obstruction underwent stent X-rays in anteroposterior and lateral views to detect fractures and Doppler to analyze arterial patency. RESULTS: we observed 12 cases with fractures (33.3%): 1 type I (2.8%), 3 type II (8.3%), 5 type III (13.9%), 3 type IV (8.3%) and no type V. According to the TASC II we had 1 in group B (8.3%), 6 in group C (50%) and 5 in group D (41.6%) p <0.004. The number of stents per limb was 3.1 (± 1.3) in cases of fracture versus 2.3 (± 1.3) in cases without fracture (p = 0.08). The extension was 274.17mm (± 100.94) in cases of fracture and 230.83mm (± 135.44) in cases without fracture (p = 0.29). On Doppler we had: 17 patients (47.2%) without stenosis, 9 patients (25%) with stenosis> 50% and 10 patients (27.8%) with occlusion (p = 0.37). There was no correlation between fracture and arterial obstruction (p = 0.33). CONCLUSION: stent fractures are a frequent finding in the femoropopliteal area (33.3%), being more prevalent in cases of more advanced disease (C and D). There was no association between the finding of fracture and arterial obstruction.
Assuntos
Procedimentos Endovasculares/métodos , Doença Arterial Periférica , Doenças Vasculares Periféricas/terapia , Artéria Poplítea , Falha de Prótese , Stents , Ultrassonografia Doppler em Cores/métodos , Humanos , Perna (Membro)/irrigação sanguínea , Doenças Vasculares Periféricas/diagnóstico por imagem , Prevalência , Desenho de Prótese , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , Grau de Desobstrução VascularRESUMO
ABSTRACT Endovascular treatment for femoropopliteal arterial disease has made revascularization procedures less invasive, but the self-expanding stents used can suffer great wear in arteries with extreme mobility. Objective: to evaluate the prevalence of fractures in stents implanted in the femoropopliteal segment, to identify predisposing factors and consequences on arterial patency. Method: between March and June 2019, thirty patients previously operated for femoropopliteal obstruction underwent stent X-rays in anteroposterior and lateral views to detect fractures and Doppler to analyze arterial patency. Results: we observed 12 cases with fractures (33.3%): 1 type I (2.8%), 3 type II (8.3%), 5 type III (13.9%), 3 type IV (8.3%) and no type V. According to the TASC II we had 1 in group B (8.3%), 6 in group C (50%) and 5 in group D (41.6%) p <0.004. The number of stents per limb was 3.1 (± 1.3) in cases of fracture versus 2.3 (± 1.3) in cases without fracture (p = 0.08). The extension was 274.17mm (± 100.94) in cases of fracture and 230.83mm (± 135.44) in cases without fracture (p = 0.29). On Doppler we had: 17 patients (47.2%) without stenosis, 9 patients (25%) with stenosis> 50% and 10 patients (27.8%) with occlusion (p = 0.37). There was no correlation between fracture and arterial obstruction (p = 0.33). Conclusion: stent fractures are a frequent finding in the femoropopliteal area (33.3%), being more prevalent in cases of more advanced disease (C and D). There was no association between the finding of fracture and arterial obstruction.
RESUMO Os tratamentos endovasculares para a doença arterial obstrutiva fêmoro-poplítea tornaram os procedimentos de revascularização menos invasivos, porém os stents metálicos autoexpansíveis utilizados podem sofrer grande desgaste em artérias com extrema mobilidade. Objetivo: avaliar a prevalência de fraturas em stents implantados no segmento fêmoro-poplíteo, identificar fatores predisponentes e possíveis consequências sobre a patência arterial. Métodos: entre março a junho de 2019, trinta pacientes previamente operados por obstrução fêmoro-poplítea realizaram RX dos stents em incidências ântero-posterior e perfil para detectar fraturas e eco Doppler para analisar a patência arterial. Resultados: observamos 12 casos com fraturas (33,3%): 1 do tipo I (2,8%), 3 do tipo II (8,3%), 5 do tipo III (13,9%), 3 do tipo IV (8,3%) e nenhuma tipo V. Segundo a classificação TASC II, tivemos 1 no grupo B (8,3%), 6 no grupo C (50%) e 5 no grupo D (41,6%) p<0,004. O número de stents por membro foi de 3,1 (±1,3) nos casos de fratura contra 2,3 (±1,3) nos casos sem fratura (p = 0,08). A extensão tratada foi 274,17mm (±100,94) nos casos de fratura e 230,83mm (±135,44) nos casos sem fratura (p=0,29). No Doppler tivemos: 17 pacientes (47,2%) sem estenose, 9 pacientes (25%) com estenose>50% e 10 pacientes (27,8%) com oclusão (p=0,37). Não houve correlação entre fratura e obstrução arterial (p=0,33). Conclusão: as fraturas de stents são um achado frequente no setor fêmoro-poplíteo (33,3%) sendo mais prevalentes nos casos de doença mais avançada TASC II C e D. Não houve associação entre o achado de fratura e obstrução arterial.
Assuntos
Humanos , Artéria Poplítea , Falha de Prótese , Stents , Doenças Vasculares Periféricas/terapia , Ultrassonografia Doppler em Cores/métodos , Doença Arterial Periférica , Procedimentos Endovasculares/métodos , Desenho de Prótese , Grau de Desobstrução Vascular , Prevalência , Estudos Retrospectivos , Fatores de Risco , Resultado do Tratamento , Doenças Vasculares Periféricas/diagnóstico por imagem , Perna (Membro)/irrigação sanguíneaRESUMO
BACKGROUND: Medical treatment of disabling intermittent claudication or critical limb-threatening ischemia causing rest pain often fails or has partial response. METHODS: In this pilot study, 36 patients (12 females) affected by disabling intermittent claudication or rest pain of the lower extremities were exposed to a daily 3-L water intake for up to 6 weeks. Cutaneous foot temperature, ankle/brachial index, time and distance of claudication, and pain intensity were recorded before and at the completion of the hydration period. RESULTS: Patients with a mean ± SE age of 71 ± 2 years (range, 40-86) had disabling claudication (less than 100 meters) for more than 5 months while 11% reported pain at rest. A 6-week water intake of more than 2,500 mL/24 hr was achieved in 35 of the 36 patients enrolled in the study. Increased water intake was associated with significant improvements in median ankle/brachial index (from 0.60 to 0.76; P < 0.0001) and skin temperature (first dorsal right toe, from 29.95°C to 30.0°C, P < 0.001). Time and distance to report claudication of supervised treadmill exercise improved from 1.25 to 6.25 min (P < 0.0001) and from 100 meters to 535 meters (P < 0.0001), respectively. CONCLUSIONS: This study suggests that hydration attained by daily water consumption of more than 2.5 L has a robust impact on reducing the symptoms of disabling claudication and rest pain caused by peripheral vascular disease.
Assuntos
Ingestão de Líquidos , Hidratação/métodos , Claudicação Intermitente/terapia , Extremidade Inferior/irrigação sanguínea , Doenças Vasculares Periféricas/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Índice Tornozelo-Braço , Argentina , Avaliação da Deficiência , Tolerância ao Exercício , Feminino , Humanos , Claudicação Intermitente/diagnóstico , Claudicação Intermitente/fisiopatologia , Masculino , Pessoa de Meia-Idade , Estado de Hidratação do Organismo , Medição da Dor , Doenças Vasculares Periféricas/diagnóstico , Doenças Vasculares Periféricas/fisiopatologia , Projetos Piloto , Estudos Prospectivos , Recuperação de Função Fisiológica , Temperatura Cutânea , Fatores de Tempo , Resultado do Tratamento , Equilíbrio HidroeletrolíticoRESUMO
INTRODUCTION: knowing patients 'believes about the medicinal utility of plants may provide a basis for educating them for a rational use of herb preparations. OBJECTIVE: to characterize the plants that are considered useful for antidiabetic, antihypertensive or hypolipidemic treatment among patients with peripheral vascular diseases. METHODS: a survey was performed among patients of the National Institute of Angiology and Vascular Surgery from February through April 2007. The characteristics of the use of plants as medicinal remedies and the names of species considered useful for the treatment of diabetes, arterial hypertension and dyslipidemia were recorded. RESULTS: two hundred and forty five both sex adult volunteers (142 female/103 male), aged 44 to 72 years) were included in the study. More than 80 % of them used medicinal plants at least occasionally and confided on their efficacy to treat different illnesses Fifteen species, mainly Allium sativum L., Citrus aurantifolia Ch., Justicia pectoralis Jacq.., Morinda citrifolia L., Ocinum sanctum L and Salvia officinalis L, from 11 botanical families, were mentioned by participants. Most patients' claims about plants´ properties have been scientifically supported in some extent, nevertheless, the majority of the pharmacological evidence relays on pre-clinical studies and results of clinical trials are not conclusive. The lack of standardized plant preparations with identified active principles and demonstrated clinical effectiveness are limitations for recommending their therapeutic use. CONCLUSION: this study has provided the first characterization of the use of plant products by patients with peripheral vascular diseases for medicinal purposes and confirmed that physicians should be aware about the possibility of herb-drug interactions that should be diagnosed. This information would aid the scientifically supported integration of Phytotherapy to the clinical practice.
INTRODUCCIÓN: el conocimiento tradicional de los pacientes sobre la utilidad de las plantas medicinales puede servir de base para su educación en el uso racional de las preparaciones herbarias. OBJETIVO: caracterizar las plantas que los pacientes con enfermedades vasculares consideran útiles para el tratamiento de la diabetes, la hipertensión y como hipolipemiante. MÉTODOS: se realizó una encuesta a los pacientes del Instituto Nacional de Angiología y Cirugía Vascular entre febrero y abril de 2007. Las características del empleo de las plantas con fines medicinales y los nombres de las especies consideradas útiles para tratar la diabetes, la hipertensión arterial y la dislipidemia fueron tabulados. RESULTADOS: doscientos cuarenta y cinco adultos voluntarios de ambos sexos (142 femeninos/103 masculinos, edad 44 a 72 años) fueron incluidos en el estudio. Más del 80 % de ellos utilizaban las plantas medicinales al menos ocasionalmente y confiaban en su eficacia para tratar diferentes enfermedades. Quince especies, fundamentalmente Allium sativum L., Citrus aurantifolia Ch., Justicia pectoralis Jacq., Morinda citrifolia L., Ocinum sanctum L. y Salvia officinalis L., pertenecientes a 11 familias botánicas, fueron mencionadas por los participantes en la encuesta. La mayoría de los planteamientos de los pacientes sobre las propiedades de estas plantas tienen algún fundamento científico, sin embargo, las evidencias farmacológicas disponibles son fundamentalmente de tipo pre-clínico y los resultados de los ensayos clínicos efectuados no son concluyentes. La carencia de preparaciones derivadas de plantas estandarizadas, con principios activos identificados y efectividad clínica demostrada, son limitaciones para recomendar su utilización terapéutica. CONCLUSIONES: esta es la primera caracterización del uso de productos de plantas con fines medicinales por pacientes con enfermedades vasculares periféricas, y confirma que los facultativos deben conocer sobre la posibilidad de interacciones planta-medicamento que deben ser diagnosticadas. Esta información ayudaría a la integración de la Fitoterapia a la práctica clínica sustentada científicamente.
Assuntos
Humanos , Plantas Medicinais/efeitos dos fármacos , Doenças Vasculares Periféricas/terapia , Dislipidemias/terapiaRESUMO
INTRODUCCIÓN: La arteriopatía periférica (AP) dificulta el flujo sanguíneo arterial dirigido a las extremidades. La prevalencia oscila en un 4,6% entre los 49 a 59 años y un 14,7% en los mayores de 70 años y es más frecuente en varones. El objetivo del tratamiento es asegurar una óptima perfusión distal para calmar el dolor y ayudar a la curación de las lesiones tróficas. Éste se basa en la modificación de los factores de riesgo, asociado al uso de vasodilatores (pentoxifilina, cilostazol) para evitar o disminuir la claudicación intermitente, y de antiagregantes (aspirina, clopidogrel) para prevenir el riesgo de complicaciones trombóticas. La presencia de isquemia crítica implica la necesidad de tratamiento de revascularización por el elevado riesgo de pérdida de la extremidad. Su incidencia se calcula en 400 individuos por millón de habitantes al año. Las técnicas para revascularizar el miembro afectado son la cirugía de derivación femoro-distal -que es técnicamente compleja y se asocia con una mortalidad perioperatoria de entre el 1,8 y el 6%- y la angioplastia transluminal percutánea (ATP) con balón con altas tasas de re-estenosis arterial, entre un 40 a 70 % al año. Por estos motivos se han desarrollado la ATP con stent (con o sin drogas antiproliferativas) y la ATP con balón liberador de drogas, con el objeto de disminuir las tasas de re estenosis arterial y de re intervenciones. TECNOLOGÍA: La ATP se realiza a través de una punción de la arteria femoral por donde se introduce un catéter que tiene en la punta un balón que se lleva hasta la arteria afectada para dilatar el segmento ocluido. Mediante este procedimiento se pueden utilizar otras estrategias como la utilización de un balón liberador de drogas (BLD) en lugar de uno convencional, o la colocación de un stent metálico, un stent liberador de drogas (SLD) o un stent autoexpandible. Tanto los BLD como los SLD suelen contener paclitaxel o sirolimus, drogas que al liberarse lentamente tienen el objetivo de inhibir la proliferación y migración de las células musculares lisas y la formación de matriz extracelular. OBJETIVO: Evaluar la evidencia disponible acerca de la eficacia, seguridad y aspectos relacionados a las políticas de cobertura del uso de tratamientos endovasculares (angioplastia transluminal percutánea con balón liberador de drogas, con stent metálico o con stent liberador de drogas) para el tratamiento de la enfermedad vascular periférica. MÉTODOS: Se realizó una búsqueda en las principales bases de datos bibliográficas (incluyendo Medline, Cochrane y CRD), en buscadores genéricos de Internet, agencias de evaluación de tecnologías sanitarias y financiadores de salud. Se priorizó la inclusión de revisiones sistemáticas, ensayos clínicos controlados aleatorizados (ECA), evaluaciones de tecnologías sanitarias y económicas, guías de práctica clínica y políticas de cobertura de otros sistemas de salud cuando estaban disponibles. RESULTADOS: No se encontraron estudios que comparen los tratamientos endovasculares evaluados con la cirugía de by-pass. Se incluyeron dos RS que comparaban los tratamientos endovasculares evaluados con ATP con balón, un ensayo clínico no incluido en las revisiones sistemáticas para BLD, nueve guías de práctica clínica, siete políticas de coberturas y tres estudios de costos.
INTRODUCTION: Peripheral artery disease (PAD) makes arterial blood flow towards the extremities difficult. Its prevalence is approximately 4.6% at 49-59 years old and approximately 14.7% over 70 years old, being more common in males. The treatment is aimed at ensuring optimal distal perfusion in order to relieve pain and help cure trophic lesions. This is based on risk factor modification, associated to the use of vasodilators (pentoxiphilin, cilostazole) to prevent or decrease intermittent claudication and of anti-platelet agents (aspirin, clopidogrel) to prevent the risk of thrombotic complications. The presence of critical ischemia results in the need for revascularization therapy due to the high risk of losing the limb. It is calculated that its incidence is 400 individuals every million inhabitants per year. The techniques used to revascularize the extremity involved include femorodistal bypass surgery -which is technically complex and is associated to a 1.8-6% perioperative mortality- and balloon percutaneous transluminal angioplasty (PTA) with high rates of arterial restenosis, which is 40 to 70% per year. This is why, stent PTA (with or without anti-proliferative drugs) and PTA with drug-eluting balloon have been developed to decrease the rates of arterial restenosis and reinterventions. TECHNOLOGY: PTA is carried out through a femoral artery puncture through which a catheter with a balloon in its end is introduced and advanced to the involved artery, to dilate the occluded segment. With this procedure, other strategies may be used such as using a drug-eluting balloon (DEB) rather than a conventional one or placing a metal stent, a drug-eluting stent (DES) or a self-expanding stent. Both DEB and DES usually contain paclitaxel or sirolimus; these are drugs which, when slowly released, are aimed at inhibiting smooth cell proliferation and migration and extracellular matrix buildup. PURPOSE: To assess the available evidence on the efficacy, safety and coverage policy related aspects on the use of endovascular therapies (percutaneous transluminal angioplasty) with drug-eluting balloon, with metal stent or drug-eluting stent) for the treatment of peripheral vascular disease. Methods: A bibliographic search was carried out on the main databases (such as MEDLINE, Cochrane and CRD), in general Internet engines, in health technology assessment agencies and health sponsors. Priority was given to including systematic reviews; controlled randomized clinical trials (RCTs); health technology assessments and economic evaluations; clinical practice guidelines and coverage policies of other health systems, when available. RESULTS: No studies comparing the endovascular therapies assessed versus bypass surgery have been found. Two SRs comparing the assessed endovascular therapies with PTA with balloon, one clinical trial not included in the systematic reviews for DEB, nine clinical practice guidelines, six coverage policies and three cost studies have been included. CONCLUSIONS: No evidence allowing to determine if endovascular therapies (angioplasty with different types of stent and DEB angioplasty) are more effective than bypass surgery has been found. As regards comparing these therapies against conventional balloon percutaneous angioplasty, the quality of the evidence found is high. For the treatment of femoropopliteal artery disease, angioplasty with drug-eluting or conventional stent and drug-eluting balloons might reduce the rates of restenosis when compared with conventional percutaneous angioplasty with balloon. Additionally, angioplasty with DEB would decrease the need for new revascularization of the treated vessel. No benefits were shown in mortality in any of the therapies assessed. The CPGs recommend that choosing the right revascularization technique will depend on the patient's comorbidity and the risk-benefit ratio of bypass vs. endovascular therapies and the type of vascular lesion. They suggest the use of stent angioplasties in surface femoral artery lesions when balloon dilatation fails, not specifying the type of stent to be used. No recommendations on drug-eluting balloons have been found.
Assuntos
Humanos , Doenças Vasculares Periféricas/terapia , Angioplastia/métodos , Procedimentos Endovasculares/métodos , Avaliação da Tecnologia Biomédica , Análise Custo-Eficiência , Cobertura de Serviços de SaúdeRESUMO
OBJETIVO: Verificar se há relação entre a medida da capacidade funcional avaliada subjetiva e objetivamente em relação ao estado atual e após tratamento clínico em pacientes com claudicação intermitente. MÉTODOS: Foram recrutados 500 pacientes com claudicação intermitente. Todos realizaram exame clínico e foram submetidos a uma avaliação funcional por meio do método subjetivo (consulta clínica) e objetivo (teste de esteira). Adicionalmente, 50 pacientes foram selecionados para se avaliar o efeito do tratamento clínico, pelos métodos subjetivo e objetivo, em relação à capacidade funcional. RESULTADOS: Dos 500 pacientes selecionados, somente 60 (12,0%) apresentaram valores referidos e observados similares. Os demais pacientes, ou seja, 440 (88,0%) apresentaram valores relatados discordantes em relação àqueles obtidos no teste de esforço. Com relação ao efeito do tratamento clínico em relação à capacidade funcional, os resultados foram similares entre ambos os métodos (χ²=1,7; p=0,427). CONCLUSÃO: Apesar de o método subjetivo superestimar os valores de capacidade funcional, quando comparados ao método objetivo, não foram observadas diferenças significantes entre ambos os métodos, quando se analisou o efeito do tratamento clínico. Assim, o método subjetivo fornece informações similares em comparação à medida objetiva no acompanhamento do tratamento clínico de pacientes com claudicação intermitente.
OBJECTIVE: To analyze if there is any relation between functional capacity assessed by subjective and objective methods regarding the current state and after clinical treatment in patients with intermittent claudication. METHODS: A total of 500 patients with intermittent claudication were enrolled. All patients underwent clinical examination and a functional evaluation by subjective (clinical visit) and objective method (treadmill test). Additionally, 50 patients were selected to evaluate the effect of clinical treatment by subjective and objective methods in relation to functional capacity. RESULTS: Out of 500 patients, only 60 (12.0%) had similar results in both methods. The remaining, that is 440 patients (88.0%) had subject values in disagreement with stress test findings. Regarding the clinical effect of the treatment on the functional outcomes, results were similar in both methods (χ²=1.7; p=0.427). CONCLUSION: Although the subjective method overestimates the functional capacity when compared to the objective method, no significant differences were observed between both methods when analyzing the effect of clinical treatment. Thus, the subjective method provides similar information as compared with objective method, in monitoring the clinical treatment of patients with intermittent claudication.
Assuntos
Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Tolerância ao Exercício , Claudicação Intermitente/terapia , Doenças Vasculares Periféricas/terapia , Avaliação de Sintomas/métodos , Autoavaliação Diagnóstica , Teste de Esforço , Claudicação Intermitente/diagnóstico , Claudicação Intermitente/etiologia , Doenças Vasculares Periféricas/complicações , Doenças Vasculares Periféricas/diagnóstico , CaminhadaRESUMO
OBJECTIVE: To analyze if there is any relation between functional capacity assessed by subjective and objective methods regarding the current state and after clinical treatment in patients with intermittent claudication. METHODS: A total of 500 patients with intermittent claudication were enrolled. All patients underwent clinical examination and a functional evaluation by subjective (clinical visit) and objective method (treadmill test). Additionally, 50 patients were selected to evaluate the effect of clinical treatment by subjective and objective methods in relation to functional capacity. RESULTS: Out of 500 patients, only 60 (12.0%) had similar results in both methods. The remaining, that is 440 patients (88.0%) had subject values in disagreement with stress test findings. Regarding the clinical effect of the treatment on the functional outcomes, results were similar in both methods (χ²=1.7; p=0.427). CONCLUSION: Although the subjective method overestimates the functional capacity when compared to the objective method, no significant differences were observed between both methods when analyzing the effect of clinical treatment. Thus, the subjective method provides similar information as compared with objective method, in monitoring the clinical treatment of patients with intermittent claudication.
Assuntos
Tolerância ao Exercício , Claudicação Intermitente/terapia , Doenças Vasculares Periféricas/terapia , Avaliação de Sintomas/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Autoavaliação Diagnóstica , Teste de Esforço , Feminino , Humanos , Claudicação Intermitente/diagnóstico , Claudicação Intermitente/etiologia , Masculino , Pessoa de Meia-Idade , Doenças Vasculares Periféricas/complicações , Doenças Vasculares Periféricas/diagnóstico , CaminhadaRESUMO
Os autores relatam um caso de tumor glômico em ramo da artéria radial que irriga o polegar direito, com história clínica de 4 meses. O doente referia o aparecimento de tumoração de aproximadamente 2,0 centímetros na região interdigital, entre o primeiro e o segundo quirodactilos da mão direita, sobre o músculo flexor curto do polegar, extremamente dolorosa e com dor em progressão. Os exames com aparelho de Doppler bidirecional e o eco-color-Doppler apresentaram, como diagnóstico presuntivo, malformação arteriovenosa, pelo turbilhonamento do fluxo e ausência de estenoses. A tumoração foi retirada por cirurgia aberta e encaminhada para exame histopatológico, com diagnóstico de glomangioma. Este relato descreve uma doença arterial pouco frequente, que causa extremo desconforto ao seu portador, mas que é solucionada pela exerese cirúrgica, sem sequelas.
We report on a case of glomus tumor in the branch of the radial artery of the right thumb. The tumor had a 4-year clinical history. The patient reported the development of a 2.0-cm tumor in the interdigital region between the first and second fingers of the right hand on the short flexor muscle of thumb. The patient also complained of severe and progressive pain. Tests using bidirectional Doppler and echo-color-Doppler revealed a presumptive diagnosis of arteriovenous malformation based on the turbulence of the flow and absence of stenosis. The tumor was removed by open surgery and sent for histopathological examination, which showed a diagnosis of glomangioma. The present report describes a rare arterial disease causing extreme discomfort to the patient, which may be treated with surgical resection without sequelae.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Doença Arterial Periférica/terapia , Tumor Glômico/cirurgia , Doenças Vasculares Periféricas/terapia , Doenças Vasculares PeriféricasRESUMO
La ateroembolia es una entidad poco conocida y cuyo pronóstico es sombrío, especialmente en aquellos cuadros de ateroembolia diseminada, pero también en casos de ateroembolia distal que provoca un síndrome inflamatorio de respuesta sistémica. Durante 14 años recopilamos 31 casos de ateroembolia, 5 de ellas postoperatorias y 26 casos con orígenes distintos: 20 debido a aorta Shaggy y 6 a otras causas. De las 20 con aorta Shaggy, 10 presentaban ateroembolia. 22 de los 26 casos no iatrogénicos fueron tratados por vía endovascular, con una mortalidad del 9%. De acuerdo a nuestras observaciones, comentamos nuestra conducta y las variaciones en el tratamiento, proponiendo una clasificación que contemple los casos asintomáticos para el tratamiento precoz de estas lesiones aórticas, antes de producir complicaciones severas por ateroembolias o síndromes isquémicos de los miembros inferiores. Asimismo, comentamos aquellos trucos que aprendimos con la observación de los distintos casos reseñados.
A ateroembolia é uma entidade pouco conhecida e cujo prognóstico é sombrio, especialmente em quadros de ateroembolia disseminada, mas que também ocorre em casos de ateroembolia distal, o que provoca uma síndrome inflamatória de resposta sistêmica. Durante 14 anos recolhemos 31 casos de ateroembolia. 5 deles, postoperatórias e 26 casos com origens diferentes: 20 devido à aorta Shaggy e 6 por outras causas. Das 20 com aorta Shaggy, 10 apresentavam ateroembolia. 22 dos 26 casos não iatrogênicos foram tratados via endovascular, com uma mortalidade de 9%. De acordo com as nossas observações, comentamos as condutas e variações no tratamento, propondo uma classificação que inclua os casos assintomáticos para o tratamento precoce destas lesões aórticas, antes de produzir complicações severas por ateroembolias ou síndromes isquêmicos dos miembros inferiores. Comentamos os truques que aprendemos com a observação dos diferentes casos selecionados.
Ateroembolism is not a very well known entity and its prognosis is poor, especially in cases of disseminated ateroembolism, and also in cases of distal ateroembolism which causes aninflammatory syndrome of systemic response. 31 cases of ateroembolism were registered during 14 years, 5 were post-surgical and 26 due to different etiologies: 20 due to shaggy aorta and 6 due to other reasons. Of the 20 cases with shaggy aorta, 10 presented ateroembolism. 22 of the 26 non-iatrogenic cases were treated with the endovascular approach with a 9% mortality. According to our observations, we discussed our approach and treatment options, suggesting a classification which includes asymptomatic cases for early treatment of these aortic lesions, before they induce severe ateroembolic complications or lower limb ischemic syndromes. Likewise, we discuss some tips learnt during the observation of the different cases commented.